Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
…, C Lindschau, F Mende, FC Luft, A Schedl, H Haller… - science, 2001 - science.org
Caveolae are plasma membrane invaginations that may play an important role in numerous
cellular processes including transport, signaling, and tumor suppression. By targeted …
cellular processes including transport, signaling, and tumor suppression. By targeted …
[HTML][HTML] Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
…, R Fagard, C Farsang, G Grassi, H Haller… - Blood …, 2009 - Taylor & Francis
GIUSEPPE MANCIAa, STÉPHANE LAURENTb, ENRICO AGABITI-ROSEIc, ETTORE
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …
Mice With Disrupted BK Channel β1 Subunit Gene Feature Abnormal Ca2+ Spark/STOC Coupling and Elevated Blood Pressure
…, R Waldschütz, M Gollasch, H Haller… - Circulation …, 2000 - Am Heart Assoc
Large-conductance potassium (BK) channels in vascular smooth muscle cells (VSMCs)
sense both changes in membrane potential and in intracellular Ca 2+ concentration. BK …
sense both changes in membrane potential and in intracellular Ca 2+ concentration. BK …
[HTML][HTML] Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
H Haller, S Ito, JL Izzo Jr, A Januszewicz… - … England Journal of …, 2011 - Mass Medical Soc
Background Microalbuminuria is an early predictor of diabetic nephropathy and premature
cardiovascular disease. We investigated whether treatment with an angiotensin-receptor …
cardiovascular disease. We investigated whether treatment with an angiotensin-receptor …
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study
…, JJM Tordoir, MG Mohaupt, FC Luft, H Haller… - Journal of the American …, 2010 - jacc.org
Objectives : This study assessed the safety and efficacy of a novel implantable device
therapy in resistant hypertension patients. Background : Despite the availability of potent …
therapy in resistant hypertension patients. Background : Despite the availability of potent …
[HTML][HTML] Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor
…, D Neichel, JW Dudenhausen, H Haller… - The Journal of …, 1999 - Am Soc Clin Investig
Immune mechanisms and the renin–angiotensin system are implicated in preeclampsia. We
investigated 25 preeclamptic patients and compared them with 12 normotensive pregnant …
investigated 25 preeclamptic patients and compared them with 12 normotensive pregnant …
[HTML][HTML] Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis
…, M Galanski, KM Koch, H Haller - … England Journal of …, 2001 - Mass Medical Soc
Background Prospectively identifying patients whose renal function or blood pressure will
improve after the correction of renal-artery stenosis has not been possible. We evaluated …
improve after the correction of renal-artery stenosis has not been possible. We evaluated …
New-onset diabetes after transplantation: 2003 international consensus GUIDELINES1
…, A Wilkinson, J Dantal, F Dotta, H Haller… - …, 2003 - journals.lww.com
Diabetes mellitus is 1one of the most common chronic diseases in the world, with an estimated
worldwide prevalence of over 176 million in 2000. Furthermore, the prevalence of the …
worldwide prevalence of over 176 million in 2000. Furthermore, the prevalence of the …
Erythropoietin regulates endothelial progenitor cells
…, B Hertel, T Duckert, SM Boehm, J Menne, H Haller… - Blood, 2004 - ashpublications.org
Circulating bone marrow–derived endothelial progenitor cells (EPCs) promote vascular
reparative processes and neoangiogenesis, and their number in peripheral blood correlates …
reparative processes and neoangiogenesis, and their number in peripheral blood correlates …
[HTML][HTML] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies …
…, AB Fogo, M Galbusera, DP Gale, H Haller… - Kidney international, 2017 - Elsevier
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement
plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 …
plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 …